Quest Diagnostics (DGX) Income from Continuing Operations (2009 - 2026)
Quest Diagnostics (DGX) posted Income from Continuing Operations of 324000000.0 for Q2 2026, up 24.62% sequentially from 260000000.0 in Q1 2026, and up 12.89% YoY from 287000000.0 in Q2 2025.
Quest Diagnostics (DGX) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Quest Diagnostics has reported Income from Continuing Operations for 18 years, with the latest figure at 324000000.0 in Q2 2026.
- Quarterly Income from Continuing Operations rose 12.89% year-over-year to 324000000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 1084000000.0 (up 12.22% YoY) and the FY2025 annual result came in at 1004000000.0, up 11.31% from the prior year.
- Income from Continuing Operations climbed to 324000000.0 in Q2 2026 per DGX's latest filing, from 260000000.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 342000000.0 in Q1 2022 and troughed at 113000000.0 in Q4 2022.
- A 5-year average of 241277777.78 and a median of 241000000.0 in 2023 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations slumped 70.88% in 2022, then surged 74.34% in 2023.
- Over 5 years, Income from Continuing Operations stood at 113000000.0 in 2022, then soared by 74.34% to 197000000.0 in 2023, then climbed by 17.26% to 231000000.0 in 2024, then advanced by 7.79% to 249000000.0 in 2025, then soared by 30.12% to 324000000.0 in 2026.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 324000000.0, 260000000.0, and 249000000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 1.76 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 870.00 Mn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | -66.93 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 339.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 241.00 Mn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 338.41 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 207.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 232.90 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 299.10 Mn |
| 10 | Quest Diagnostics | 27.10 Bn | 26.47 Bn | 1.03 Bn | 324.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 324.00 Mn |
| Mar 31, 2026 | 260.00 Mn |
| Dec 31, 2025 | 249.00 Mn |
| Sep 30, 2025 | 251.00 Mn |
| Jun 30, 2025 | 287.00 Mn |
| Mar 31, 2025 | 217.00 Mn |
| Dec 31, 2024 | 231.00 Mn |
| Sep 30, 2024 | 231.00 Mn |
| Jun 30, 2024 | 240.00 Mn |
| Mar 31, 2024 | 200.00 Mn |
| Dec 31, 2023 | 197.00 Mn |
| Sep 30, 2023 | 231.00 Mn |
| Jun 30, 2023 | 242.00 Mn |
| Mar 31, 2023 | 212.00 Mn |
| Dec 31, 2022 | 113.00 Mn |
| Sep 30, 2022 | 270.00 Mn |
| Jun 30, 2022 | 246.00 Mn |
| Mar 31, 2022 | 342.00 Mn |
| Dec 31, 2021 | 388.00 Mn |
| Sep 30, 2021 | 501.00 Mn |